• Something wrong with this record ?

Permeation enhancers in transdermal drug delivery: benefits and limitations

A. Kováčik, M. Kopečná, K. Vávrová,

. 2020 ; 17 (2) : 145-155. [pub] 20200114

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

Introduction: Transdermal drug delivery has several clinical benefits over conventional routes of drug administration. To open the transdermal route for a wider range of drugs, including macromolecules, numerous physical and chemical techniques to overcome the natural low skin permeability have been developed.Areas covered: This review focuses on permeation enhancers (penetration enhancers, percutaneous absorption promoters or accelerants), which are chemicals that increase drug flux through the skin barrier. First, skin components, drug permeation pathways, and drug properties are introduced. Next, we discuss properties of enhancers, their various classifications, structure-activity relationships, mechanisms of action, reversibility and toxicity, biodegradable enhancers, and synergistic enhancer combinations.Expert opinion: Overcoming the remarkable skin barrier properties in an efficient, temporary and safe manner remains a challenge. High permeation-enhancing potency has long been perceived to be associated with toxicity and irritation potential of such compounds, which has limited their further development. In addition, the complexity of enhancer interactions with skin, formulation and drug, along with their vast chemical diversity hampered understanding of their mechanisms of action. The recent development in the field revealed highly potent yet safe enhancers or enhancer combinations, which suggest that enhancer-aided transdermal drug delivery has yet to reach its full potential.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028550
003      
CZ-PrNML
005      
20210114154226.0
007      
ta
008      
210105s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/17425247.2020.1713087 $2 doi
035    __
$a (PubMed)31910342
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kováčik, Andrej $u Skin Barrier Research Group, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
245    10
$a Permeation enhancers in transdermal drug delivery: benefits and limitations / $c A. Kováčik, M. Kopečná, K. Vávrová,
520    9_
$a Introduction: Transdermal drug delivery has several clinical benefits over conventional routes of drug administration. To open the transdermal route for a wider range of drugs, including macromolecules, numerous physical and chemical techniques to overcome the natural low skin permeability have been developed.Areas covered: This review focuses on permeation enhancers (penetration enhancers, percutaneous absorption promoters or accelerants), which are chemicals that increase drug flux through the skin barrier. First, skin components, drug permeation pathways, and drug properties are introduced. Next, we discuss properties of enhancers, their various classifications, structure-activity relationships, mechanisms of action, reversibility and toxicity, biodegradable enhancers, and synergistic enhancer combinations.Expert opinion: Overcoming the remarkable skin barrier properties in an efficient, temporary and safe manner remains a challenge. High permeation-enhancing potency has long been perceived to be associated with toxicity and irritation potential of such compounds, which has limited their further development. In addition, the complexity of enhancer interactions with skin, formulation and drug, along with their vast chemical diversity hampered understanding of their mechanisms of action. The recent development in the field revealed highly potent yet safe enhancers or enhancer combinations, which suggest that enhancer-aided transdermal drug delivery has yet to reach its full potential.
650    _2
$a aplikace kožní $7 D000279
650    _2
$a zvířata $7 D000818
650    _2
$a lékové transportní systémy $7 D016503
650    _2
$a lidé $7 D006801
650    _2
$a permeabilita $7 D010539
650    _2
$a léčivé přípravky $x aplikace a dávkování $x metabolismus $7 D004364
650    _2
$a kůže $x metabolismus $7 D012867
650    12
$a kožní absorpce $7 D012869
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Kopečná, Monika $u Skin Barrier Research Group, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
700    1_
$a Vávrová, Kateřina $u Skin Barrier Research Group, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
773    0_
$w MED00193514 $t Expert opinion on drug delivery $x 1744-7593 $g Roč. 17, č. 2 (2020), s. 145-155
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31910342 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114154223 $b ABA008
999    __
$a ok $b bmc $g 1608885 $s 1119730
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 17 $c 2 $d 145-155 $e 20200114 $i 1744-7593 $m Expert opinion on drug delivery $n Expert Opin Drug Deliv $x MED00193514
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...